Barry, A L <br/><br/>
Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres.  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  Nov 1998 
 - 651-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0305-7453 
<br/><br/><label>Standard No.: </label>10.1093/jac/42.5.651  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Academic Medical Centers<br/>Anti-Bacterial Agents--pharmacology<br/>Drug Resistance, Microbial<br/>Enterococcus--drug effects<br/>Erythromycin--pharmacology<br/>Gram-Positive Bacterial Infections--microbiology<br/>Gram-Positive Cocci--drug effects<br/>Humans<br/>Microbial Sensitivity Tests<br/>North America<br/>Staphylococcus--drug effects<br/>Streptococcus--drug effects<br/>Virginiamycin--pharmacology